| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0005 |